The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.

Carrera, Pricivel M; Kantarjian, Hagop M; Blinder, Victoria S

Carrera, Pricivel M; Kantarjian, Hagop M; Blinder, Victoria S.

Afiliación

Carrera PM; Assistant Professor, Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Kantarjian HM; Professor and Chairman, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blinder VS; Medical Oncologist, Immigrant Health and Cancer Disparities Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.

CA Cancer J Clin ; 68(2): 153-165, 2018 03.

Article en En | MEDLINE | ID: mdl-29338071

Asunto(s)

Antineoplásicos/economía; Costo de Enfermedad; Financiación Personal/estadística & datos numéricos; Costos de la Atención en Salud; Neoplasias/tratamiento farmacológico; Neoplasias/economía; Neoplasias/psicología; Estrés Psicológico/economía; Política de Salud; Humanos

Palabras clave

antineoplastic agents; costs and cost analysis; decision making; health financing; oncologists; precision medicine; referral and consultation; supportive care

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estrés Psicológico / Costos de la Atención en Salud / Costo de Enfermedad / Financiación Personal / Neoplasias / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google